Skip to main content

GlucoTab

GlucoTab is a clinical decision support software that helps hospital and care facility staff manage diabetes therapy. The system optimizes blood glucose management workflows and automatically recommends safe insulin doses, with algorithms validated through extensive clinical studies. It supports multiple therapy modes, including basal-bolus, basal-supported, physician-directed, and patient self-management.

Graz, Austria · HQ
Founded 20168200+ followers
  • Artificial Intelligence
  • Digital Health
  • Healthcare Technology
  • Software Only
Updated 10 days ago

Funding

Raised to date

$4.3MRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.

across 1 round

E

Founders

Founder details are not available yet.

Product

Problem

Hospitalized patients with diabetes require frequent blood glucose monitoring and precise insulin dosing, which is time-consuming and error-prone for medical staff. Manual calculation of insulin doses based on blood glucose levels, meal intake, and individual patient factors increases the risk of hypo- or hyperglycemia and places a significant documentation burden on nurses and physicians.

Solution

GlucoTab provides a clinical decision support system that digitizes and optimizes blood glucose management workflows in hospitals and care facilities. The software automatically calculates safe insulin doses based on evidence-based, clinically validated therapy algorithms, supporting physicians and nursing staff in treatment decisions. It offers multiple therapy modes, including basal-bolus therapy, basal-supported therapy for geriatric patients, physician-directed therapy, and patient self-management. The system includes an electronic diabetes chart that visualizes all relevant steps and tracks open tasks for doctors and nurses, ensuring consistent and transparent care. GlucoTab is available in six languages and has been successfully deployed across numerous European healthcare institutions.

Target Audience

Primary users are physicians and nursing staff in hospitals and care facilities who manage diabetes therapy for inpatient and geriatric patients, as well as trained patients who self-manage their insulin dosing during hospitalization.

Features

  • Automated insulin dose calculation for therapy initiation, daily dose adjustment, and meal-related bolus dosing based on current blood glucose values
  • Support for multiple therapy regimens including basal-bolus, basal-supported (BOT/BIT), physician-directed, and patient self-management
  • Bolus calculator for intensified insulin therapy with carbohydrate and correction factors
  • Electronic diabetes chart with task management and workflow visualization for physicians and nursing staff
  • Flexible prescription options covering long-acting and short-acting insulin, fixed doses, correction schemes, mixed insulin, incretins, and oral antidiabetics
  • Multilingual interface supporting six languages (version 10.1, March 2025)
This profile is AI-generated and may contain inaccuracies.